Announced Mon, 13 Jul · 19:41 IST
Vivo Bio Tech Q1 FY27 results: revenue up, profit plunges
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-9.3%1-day move
₹25.54
prior close
₹25.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.3———-9.3-7.8-8.0-6.4-8.0-9.9————
Up moveDown movePending
AI summary
Vivo Bio Tech posted Q1 FY26-27 results. Consolidated revenue rose to Rs 1,427.97 lakh from Rs 1,251.16 lakh year ago, about 14 percent growth. However, net profit crashed to Rs 18.76 lakh from Rs 133.71 lakh, a drop of roughly 86 percent. Standalone revenue was Rs 1,413.94 lakh with PAT of Rs 18.43 lakh versus Rs 137.32 lakh earlier. Total expenses grew faster than revenue, mainly on higher employee costs, purchase of traded goods and depreciation, sharply squeezing margins.
Likely market impact
Sharp fall in profit despite revenue growth signals margin pressure. Weak earnings may be viewed negatively by investors in the near term.